Home » Topics » Disease categories and therapies » Urology

Urology
RSS

ProMetic reveals agent under development for diabetic nephropathy

Nov. 18, 2015

Sophiris Bio reports results from phase III trial of PRX-302 in BPH

Nov. 13, 2015

Antagonism of CCR2/5 in type 2 diabetic nephropathy

Nov. 9, 2015

SUL-121, a novel candidate to treat diabetic nephropathy

Nov. 9, 2015

Preclinical toxicity study results for Pyridorin will support planned IND filing

Nov. 9, 2015

Quark Pharmaceuticals plans new trials of QPI-1002

Nov. 3, 2015

Isis Pharmaceuticals begins phase II study of ISIS-FXIRx in end-stage renal disease

Nov. 3, 2015

Taiho starts phase I trial of TAS-303 in women with stress urinary incontinence

Nov. 3, 2015

Revive Therapeutics' bucillamine receives orphan drug designation for cystinuria

Oct. 30, 2015

Researchers devise mouse model of nocturnal polyuria

Oct. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...